Skip to main content

Table 1 The relationship between sample clusters and clinical characteristics of glioma patients

From: Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analyses

  

Cluster1

Cluster2

P

Treatment

no PRT

16

108

3.04E−05

 

RT

7

67

 
 

PT

6

48

 
 

PT + RT

95

247

 

Age

 > 60

56

80

7.33E−11

 

 < 60

68

390

 

Gender

male

78

262

0.1831

 

female

46

208

 

IDH

IDH-mut

15

321

 < 2.2e−16

 

IDH-wt

78

89

 

Grade

G2

4

186

 < 2.2e−16

 

G3

19

195

 
 

G4

70

29

 

MGMT

Methylated

43

334

3.76E−12

 

Unmethylated

50

76

 
  1. no PRT no Pharmacotherapy and radiotherapy; PT Pharmacotherapy; RT radiotherapy